Search The Medical Knowledge Base
Medical News by Category
Rheumatoid Arthritis News
- FDA Advisory Committee recommends tofacitinib (Pfizer) for Rheumatoid Arthritis
Published: Wednesday 09 May 2012
- AbbVie is the new Abbott research based pharma company
Published: Thursday 22 March 2012
- C-EARLY Phase III study of Cimzia (UCB) begins for Rheumatoid Arthritis patients
Published: Friday 24 February 2012
- NICE updates advice allowing earlier use of RoActemra/Actemra (Roche) for Rheumatoid Arthritis
Published: Friday 24 February 2012
- FDA to review tofacitinib(Pfizer) for Rheumatoid Arthritis in August 2012
Published: Thursday 22 December 2011
- FDA accepts filing of Lodotra (Horizon Pharma) for Rheumatoid Arthritis
Published: Wednesday 30 November 2011
- Tofacitinib (Pfizer) is filed at EMA for Rheumatoid Arthritis
Published: Monday 21 November 2011
- Rheumatoid Arthritis Trial shows week 12 response to Cimzia (UCB) predicts response at 1 year.
Published: Saturday 12 November 2011
- Enbrel (Amgen/Pfizer) shows clear benefits for patients with moderately active Rheumatoid Arthritis
Published: Friday 11 November 2011
- Humira (Abbott) and other tumour necrosis factor-antagonists are not linked to increased serious infection rate
Published: Tuesday 08 November 2011